Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Item
http://www.wikidata.org/entity/Q26801716
Prophylactic Measures During Induction for Acute Myeloid Leukemia.Polycythemia Vera Management and Challenges in the Community Health Setting.Duration of Antiviral Prophylaxis and Risk of Herpes Zoster among Patients Receiving Autologous Hematopoietic Stem Cell Transplants: A Retrospective, Observational StudyIs There a Role for Opportunistic Infection Prophylaxis in Pemphigus? An Expert Survey.Optimizing antiviral agents for hepatitis B management in malignant lymphomas.Predicting risk factors for varicella zoster virus infection and postherpetic neuralgia after hematopoietic cell transplantation using ordered logistic regression analysis.Varicella-Zoster Virus Gastritis: Case Report and Review of the Literature.Herpetic tracheitis in association with rituximab therapy.[Herpes zoster and postherpetic neuralgia].Prophylaxis for hepatitis B reactivation during and after chemotherapy: many questions, some answers.Screening for viral hepatitis prior to rituximab chemotherapy.Healthcare utilization and costs among patients with herpes zoster and solid tumor malignancy on chemotherapy: A retrospective cohort study.Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.Liver Illness and Psoriatic Patients.Consensus statement for cancer patients requiring intensive care support.Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).
P2860

Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Item
http://www.wikidata.org/entity/Q26801716
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@ast
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@en
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@nl
type
label
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@ast
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@en
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@nl
prefLabel
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@ast
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@en
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@nl
P1433
P1476
P2093
P275
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P5008
P577
P5875
P698
P921
P932
P3181
P356
P1433
P1476
Antiviral prophylaxis in patie ...... gy and Medical Oncology (DGHO)
@en
P2093
P275
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P5008
P577
P5875
P698
P921
P932